I am a pharmaceutical scientist with expertise in drug formulation, drug delivery systems, and cancer biology. My research interest is developing innovative approaches to precision medicine in cancer treatment. My previous projects involved redesigning existing chemotherapeutics as targeted polymer-drug conjugates to prevent adverse side effects and improve therapeutic outcomes in ovarian cancer. I am currently investigating the molecular mechanisms of cancer resistance in targeted chemotherapy and identifying novel strategies to enhance therapeutic effectiveness in cancer treatment.
I am a pharmaceutical scientist with expertise in drug formulation, drug delivery systems, and cancer biology. My research interest is developing innovative approaches to precision medicine in cancer treatment. My previous projects involved redesigning existing chemotherapeutics as targeted polymer-drug conjugates to prevent adverse side effects and improve therapeutic outcomes in ovarian cancer. I am currently investigating the molecular mechanisms of cancer resistance in targeted chemotherapy and identifying novel strategies to enhance therapeutic effectiveness in cancer treatment.